Bio-Quant has two businesses: a drug development effort and contract research services. Thus far, the Company has been supporting its operations and the development of its internal drug programs into human “proof-of-concept” clinical trials by generating revenues from its contract services business.

Bio-Quant is strategically positioned to become a leading biotechnology company. Our strategy is to use our expertise to:

• Identify and acquire biotechnology product candidates
• Form strategic partnership for development of our product candidates
• Improve the Company’s financial position by receiving licensing and milestone payments from these partnerships
• Reduce risk by developing a strong product pipeline